Correlation of ABCD3 expression with clinicopathological features showed a positive correlation with patients' age (P = 0.0018), with Gleason score (P = 0.0127), and with well-to-moderately differentiated and poorly differentiated prostate tumors (P = 0.0009). This evidence concerns the gene ABCD3 and prostate neoplasm.